Friday, May 3, 2024
ADVT 
Health

Researchers working on Covid vaccine that people can drink

Darpan News Desk IANS, 23 Jan, 2023 01:58 PM
  • Researchers working on Covid vaccine that people can drink

San Francisco, Jan 23 (IANS) Researchers are working on a Covid-19 vaccine that people may drink instead of receiving with a needle, expanding their focus onto mucosal vaccines, which include nasal vaccines as well as "swish and swallow" oral vaccines.

The vaccine, called QYNDR, completed its phase 1 clinical trial and is currently waiting on more funding to conduct the more detailed, advanced trials that could actually bring the vaccine to market, reports CNET.

"The QYNDR vaccine is pronounced 'kinder', because it's a softer way to deliver a vaccine," Kyle Flanigan, founder of QYNDR's maker, US Specialty Formulations, was quoted as saying.

Moreover, the report said that promising clinical trial results from New Zealand offer hope that QYNDR will be a viable option for protection against the string of Covid-19 variants circulating now.

"It's really challenging to have a vaccine survive making it through your digestive system," Flanigan said.

"We were able to figure out how to get a vaccine past the stomach and into the gut and have it be effective and induce the appropriate response," she added.

Scientists are hopeful that mucosal vaccines will not only protect against severe diseases and death, as revolutionary mRNA vaccines and boosters have but also ward off infections, the report said.

Different from traditional vaccines, mucosal vaccines enter through our mucous membranes, either through our nose (as in the much-discussed nasal Covid-19 vaccine) or through our gut (as in the orally suspended QYNDRs).

Mucosal vaccines have been supported as viable, or even preferable, options for combating Covid-19 infections due to the different types of immunity they produce and the fact that it begins right where the virus enters our bodies, the report mentioned.

MORE Health ARTICLES

Long term effect on heart health post Covid vaccination

Long term effect on heart health post Covid vaccination
 Additionally, reports suggest that Covid-19 vaccines are not only safe for people with heart diseases, but they are also very important. We are at a point where there is a growing risk of emerging variants, there heart patient being one of the most vulnerable populations in the society need to get their vaccine shots as soon as possible.

Long term effect on heart health post Covid vaccination

Support your happiness with positive psychology

Support your happiness with positive psychology
To achieve a well-balanced and a meaningful life one needs to have a positive psyche and do away with all the negativity within. It is a known fact that humans respond well to positive emotions and stay motivated under its influence.

Support your happiness with positive psychology

Overcome your dental anxiety and fears

Overcome your dental anxiety and fears
The more you procrastinate, the higher your risk of developing dental problems. Visiting your dentist regularly can actually make the entire process easier on many levels. Richa Vats, a doctor and Geriatric Dentist shares how to deal with dental anxiety and overcome any fears. 

Overcome your dental anxiety and fears

When does a heat wave become a health hazard?

When does a heat wave become a health hazard?
Soaring temperatures eased Wednesday in parts of British Columbia, Yukon and Northwest Territories, but were expected to remain in high in eastern British Columbia and the Prairies for several days. 

When does a heat wave become a health hazard?

Cancer patients at risk by 2nd dose delay: experts

Cancer patients at risk by 2nd dose delay: experts
Pfizer recommends a 21-day interval between shots of its two-dose vaccine, and like several provinces, British Columbia does not offer medical exemptions for higher risk cancer patients like Martinson.

Cancer patients at risk by 2nd dose delay: experts

FDA OKs first new ADHD drug in over a decade for children

FDA OKs first new ADHD drug in over a decade for children
The Food and Drug Administration late Friday OK’d Qelbree (KELL’-bree) for treating attention deficit hyperactivity disorder in children ages 6 to 17. It comes as a capsule that’s taken daily.

FDA OKs first new ADHD drug in over a decade for children